Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA; Multiple Leiomyoma Consortium.

Nat Genet. 2002 Apr;30(4):406-10. Epub 2002 Feb 25.

PMID:
11865300
2.
3.

Uterine fibroids.

Stewart EA.

Lancet. 2001 Jan 27;357(9252):293-8. Review.

PMID:
11214143
4.

Allelotype of uterine leiomyomas.

Mao X, Barfoot R, Hamoudi RA, Easton DF, Flanagan AM, Stratton MR.

Cancer Genet Cytogenet. 1999 Oct 15;114(2):89-95.

PMID:
10549262
5.

Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary.

Sakurada A, Suzuki A, Sato M, Yamakawa H, Orikasa K, Uyeno S, Ono T, Ohuchi N, Fujimura S, Horii A.

Jpn J Cancer Res. 1997 Nov;88(11):1025-8.

PMID:
9439675
6.

Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.

Packenham JP, du Manoir S, Schrock E, Risinger JI, Dixon D, Denz DN, Evans JA, Berchuck A, Barrett JC, Devereux TR, Ried T.

Mol Carcinog. 1997 Aug;19(4):273-9.

PMID:
9290705
7.

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J.

Cancer Res. 1997 Sep 1;57(17):3657-9.

8.

Low incidence of BRCA2 mutations in breast carcinoma and other cancers.

Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AK, Kamb A.

Nat Genet. 1996 Jun;13(2):241-4.

PMID:
8640236
9.

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA.

Nat Genet. 1996 Jun;13(2):238-40.

PMID:
8640235
10.

Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.

Ganguly A, Rock MJ, Prockop DJ.

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10325-9. Erratum in: Proc Natl Acad Sci U S A 1994 May 24;91(11):5217.

11.

BRCA1 mutations in primary breast and ovarian carcinomas.

Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al.

Science. 1994 Oct 7;266(5182):120-2.

PMID:
7939630
12.

Antioncogenes and human cancer.

Knudson AG.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10914-21. Review.

Supplemental Content

Support Center